Amedeo Smart

Free Medical Literature Service


 

Amedeo

Anemia

  Free Subscription

Articles published in
Transfusion
    March 2024
  1. JORGENSEN CC, Michelsen C, Petersen T, Kehlet H, et al
    Preoperative hemoglobin thresholds for increased risk of "medical" complications in fast-track total hip and knee arthroplasty, a secondary analysis of a machine-learning algorithm.
    Transfusion. 2024;64:438-442.
    >> Share

  2. ISRAELYAN N, Vege S, Friedman DF, Zhang Z, et al
    RH genotypes and red cell alloimmunization rates in chronically transfused patients with sickle cell disease: A multisite study in the USA.
    Transfusion. 2024;64:526-535.
    >> Share

    February 2024
  3. CAO J, Lu S, Luo D, Pei R, et al
    Successful treatment pure red cell aplasia after ABO major mismatched allogeneic hematopoietic stem cell transplantation with avatrombopag and low dose rituximab.
    Transfusion. 2024 Feb 13. doi: 10.1111/trf.17743.
    >> Share

  4. PETERMANN S, Mayer V, Carbol A, Opitz A, et al
    Compound heterozygosity induces a rare Gerbich-negative phenotype in an immunized blood donor.
    Transfusion. 2024;64:406-411.
    >> Share

  5. MO A, Wood E, Shortt J, Charlton A, et al
    Rethinking the transfusion pathway in myelodysplastic syndromes: Study protocol for a novel randomized feasibility n-of-1 trial of weekly-interval red cell transfusion in myelodysplastic syndromes.
    Transfusion. 2024;64:236-247.
    >> Share

    January 2024
  6. CIGNA M, Leiva-Torres GA, Baillargeon N, Yanez JC, et al
    Management of a patient with sickle cell disease and multiple red blood cell alloantibodies in preparation for a hematopoietic stem cell transplantation.
    Transfusion. 2024 Jan 11. doi: 10.1111/trf.17715.
    >> Share

  7. BRANCAMP R, Hughes CE, Dar A, Polic A, et al
    Homozygous SPTA1-associated hereditary pyropoikilocytosis presenting as hydrops fetalis.
    Transfusion. 2024;64:189-193.
    >> Share

  8. LIPMAN T, Bienz MN, Pendergrast J, Cserti-Gazdewich C, et al
    Unexpected difficulty in performance of a monocyte monolayer assay when using RBCs from a patient with sickle cell disease.
    Transfusion. 2024;64:4-5.
    >> Share

  9. STEVENS-HERNANDEZ CJ, Gyorffy G, Meli A, New HV, et al
    Vesiculation in irradiated and cation-leaky-stored red blood cells.
    Transfusion. 2024;64:150-161.
    >> Share

    December 2023
  10. CALJE E, Oyston C, Wang Z, Bloomfield F, et al
    The fatigue after infusion or transfusion pilot trial and feasibility study: A three-armed randomized pilot trial of intravenous iron and blood transfusion for the treatment of postpartum anemia.
    Transfusion. 2023 Dec 27. doi: 10.1111/trf.17621.
    >> Share

  11. MERCURE-CORRIVEAU N, Crowe EP, Vozniak S, Feng X, et al
    Euvolemic automated transfusion to treat severe anemia in sickle cell disease patients at risk of circulatory overload.
    Transfusion. 2023 Dec 8. doi: 10.1111/trf.17613.
    >> Share

  12. CROWE EP, Hasan R, Saifee NH, Bakhtary S, et al
    How do we perform intrauterine transfusions?
    Transfusion. 2023;63:2214-2224.
    >> Share

  13. KAYANO SS, Santana PV, Colella R, Colella MP, et al
    Lower platelet count and metastatic tumor are associated with increased risk of spontaneous bleeding in critically ill patients with cancer: An observational study.
    Transfusion. 2023;63:2311-2320.
    >> Share

    November 2023
  14. RYDEN J, Clements M, Wikman A, Hellstrom-Lindberg E, et al
    Red blood cell alloimmunization in myelodysplastic syndromes: Associations with sex, DAT-positivity, and increased transfusion needs.
    Transfusion. 2023;63:2040-2051.
    >> Share

    October 2023
  15. GOLLAMUDI J, Dasgupta SK, Thiagarajan P
    Erythrophagocytosis in autoimmune immunoglobulin A-mediated hemolysis.
    Transfusion. 2023;63:1978-1982.
    >> Share

    September 2023
  16. ABELS E, Jacobs JW, Prior D, Willets LC, et al
    Passive transfer of alloantibodies through breast milk as a mediator of hemolytic anemia.
    Transfusion. 2023 Sep 14. doi: 10.1111/trf.17548.
    >> Share

    August 2023
  17. SOTOLONGO G, Poisson JL
    Increased red blood cell alloimmunization rates in transfused aplastic anemia and myelofibrosis patients.
    Transfusion. 2023 Aug 30. doi: 10.1111/trf.17529.
    >> Share

  18. LASOCKI S, Delahaye D, Fuks D, Savoie PH, et al
    Management of perioperative iron deficiency anemia as part of patient blood management in France: A budget impact model-based analysis based on real world data.
    Transfusion. 2023 Aug 23. doi: 10.1111/trf.17495.
    >> Share

  19. ARYA S, Xiang T, Tang GH, Pavenski K, et al
    Including the patient in patient blood management: Development and assessment of an educational animation tool.
    Transfusion. 2023;63:1488-1494.
    >> Share

    July 2023
  20. ABDELHAY A, Mahmoud AA, Ammari O, Dalbah R, et al
    Outcomes of therapeutic plasma exchange in severe autoimmune hemolytic anemia hospitalizations: An analysis of the National Inpatient Sample.
    Transfusion. 2023 Jul 3. doi: 10.1111/trf.17445.
    >> Share

  21. WEBB CB, Yates SG, Sarode R, Kim J, et al
    Plasma exchange-A useful adjunct therapy to red cell exchange in patients with sickle cell disease and multiorgan dysfunction.
    Transfusion. 2023;63:1384-1390.
    >> Share

  22. HAW J, Walrond J, Jayachandran J, Dordunoo D, et al
    Sickle cell disease and the need for blood: Barriers to donation for African, Caribbean, and Black young adults in Canada.
    Transfusion. 2023;63:1324-1332.
    >> Share

    June 2023
  23. DESIMONE RA, Plimier C, Goel R, Hendrickson JE, et al
    Associations of donor, component, and recipient factors on hemoglobin increments following red blood cell transfusion in very low birth weight infants.
    Transfusion. 2023 Jun 30. doi: 10.1111/trf.17468.
    >> Share

  24. WALL E, Bolster L
    Complications of red cell exchange for anemia management in patients with transfusion-dependent thalassemia.
    Transfusion. 2023 Jun 15. doi: 10.1111/trf.17419.
    >> Share

  25. STEFFEN KM, Spinella PC, Holdsworth LM, Ford M, et al
    Factors influencing pediatric transfusion: A complex decision impacting quality of care.
    Transfusion. 2023;63:1151-1160.
    >> Share

    May 2023
  26. CARTER PW, Dunham AJ
    Modeling hemoglobin levels of patients chronically transfused with red blood cells.
    Transfusion. 2023;63:952-959.
    >> Share

  27. SHAULOV A, Rund D, Filon D, Nachmias B, et al
    Successful treatment with plasma exchange in life-threatening hyperhemolytic syndrome unrelated to sickle cell disease.
    Transfusion. 2023;63:1100-1106.
    >> Share

  28. YAZER MH, Spinella PC, Sperry J, Triulzi DJ, et al
    Timing of RhD-positive red blood cell administration is associated with D-alloimmunization in injured patients.
    Transfusion. 2023;63 Suppl 3:S54-S59.
    >> Share

    April 2023
  29. GOEL R, Roubinian NH, Bembea MM
    Disentangling the causes of RBC loss and anemia in ECMO patients: Some questions answered?
    Transfusion. 2023 Apr 10. doi: 10.1111/trf.17347.
    >> Share

    March 2023
  30. JUTRAS C, Sauthier M, Tucci M, Trottier H, et al
    Prevalence and determinants of anemia at discharge in pediatric intensive care survivors.
    Transfusion. 2023 Mar 12. doi: 10.1111/trf.17309.
    >> Share

  31. COSTA V, Mercure-Corriveau N, Gourneau J, Tobian AAR, et al
    Transfusion-transmitted babesiosis in a patient with sickle cell disease undergoing chronic red cell exchange.
    Transfusion. 2023;63:652-655.
    >> Share

  32. ALLISON D, Manon L, Vidanovic V, Crane J, et al
    How do we operate a large monthly red blood cell exchange program.
    Transfusion. 2023;63:450-456.
    >> Share

  33. CROWDER LA, Cable RG, Spencer BR
    Validity of donor-reported iron supplementation practices obtained at the time of donation.
    Transfusion. 2023;63:470-475.
    >> Share

  34. HAJJAJ OI, Cserti-Gazdewich C, Dumevska L, Hanna M, et al
    Reconsidering sickle cell trait testing of red blood cell units allocated to children with sickle cell disease.
    Transfusion. 2023;63:507-514.
    >> Share

    February 2023
  35. DAVIES AT, Devlin PM, Dugan C, Richards T, et al
    Non-erythropoiesis stimulating agent, non-iron therapies for the management of anemia: A scoping review.
    Transfusion. 2023 Feb 22. doi: 10.1111/trf.17274.
    >> Share

  36. DELAFORCE A, Farmer S, Duff J, Munday J, et al
    Results from a type two hybrid-effectiveness study to implement a preoperative anemia and iron deficiency screening, evaluation, and management pathway.
    Transfusion. 2023 Feb 21. doi: 10.1111/trf.17287.
    >> Share

  37. GHESQUIERE L, Leroy J, Deken V, Tournier A, et al
    Anti-RH1 alloimmunization: At what maternal antibody threshold is there a risk of severe fetal anemia?
    Transfusion. 2023 Feb 3. doi: 10.1111/trf.17264.
    >> Share

  38. TRAN A, Yan MTS, Branch DR, Blacquiere M, et al
    Severe fetal anemia caused by anti-Jr(a) : Burst forming unit-erythroid colony formation inhibition assay suggesting possible erythroid suppression mechanism.
    Transfusion. 2023 Feb 2. doi: 10.1111/trf.17265.
    >> Share

  39. HE Y, Gao W, Li Y, Xu C, et al
    A single-center, retrospective analysis of 17 cases of hemolytic disease of the fetus and newborn caused by anti-M antibodies.
    Transfusion. 2023 Feb 2. doi: 10.1111/trf.17249.
    >> Share

  40. ALSAGHIR A, Alsaghir L, Alsaif J, Mobeireek A, et al
    Successful therapeutic plasma exchange for a patient with sickle cell disease and fat embolism syndrome after a failure of a response to red cell exchange transfusion.
    Transfusion. 2023;63 Suppl 1:S33-S36.
    >> Share

  41. LENET T, Skanes S, Tropiano J, Verret M, et al
    Patient perspectives on intraoperative blood transfusion: A qualitative interview study with perioperative patients.
    Transfusion. 2023;63:305-314.
    >> Share

    January 2023
  42. JACOBS JW, Abels E, Binns TC, Tormey CA, et al
    Warm autoimmune hemolytic anemia with anti-Jk(a) specificity following babesiosis masquerading as a delayed hemolytic transfusion reaction.
    Transfusion. 2023 Jan 17. doi: 10.1111/trf.17252.
    >> Share

  43. HORNEDO-GONZALEZ KD, Jacob AK, Burt JM, Higgins AA, et al
    Non-invasive hemoglobin estimation for preoperative anemia screening.
    Transfusion. 2023 Jan 5. doi: 10.1111/trf.17237.
    >> Share

    December 2022
  44. RINGEL F, Kiesewetter H, Mayer B, Bartolmas T, et al
    Silvernanoparticle-induced hemolysis confounded with direct antiglobulin test-negative autoimmune hemolytic anemias diagnosis.
    Transfusion. 2022;62:2648-2652.
    >> Share

    November 2022
  45. MAISONNEUVE E, Sohier Lepine M, Maurice P, Pissard S, et al
    Prenatal management of fetal anemia due to pyruvate kinase deficiency: A case report.
    Transfusion. 2022 Nov 8. doi: 10.1111/trf.17177.
    >> Share

    October 2022
  46. KARAFIN MS, Field JJ, Ilich A, Li L, et al
    Hypoxic storage of donor red cells preserves deformability after exposure to plasma from adults with sickle cell disease.
    Transfusion. 2022 Oct 30. doi: 10.1111/trf.17163.
    >> Share

  47. TEAWTRAKUL N, Songdej D, Hantaweepant C, Tantiworawit A, et al
    Red blood cell alloimmunization and other transfusion-related complications in patients with transfusion-dependent thalassemia: A multi-center study in Thailand.
    Transfusion. 2022;62:2039-2047.
    >> Share

  48. ANTHON CT, Granholm A, Sivapalan P, Zellweger N, et al
    Prophylactic platelet transfusions versus no prophylaxis in hospitalized patients with thrombocytopenia: A systematic review with meta-analysis.
    Transfusion. 2022;62:2117-2136.
    >> Share

  49. KRULL A, Thompson T, Strasburg D, DiGuardo M, et al
    How do I warm HPC(A) products to maximize cell viability in the setting of cold agglutinin disease?
    Transfusion. 2022;62:1942-1947.
    >> Share

  50. GERRITSMA JJ, van der Bolt N, van Bruggen R, Ten Brinke A, et al
    Measurement of post-transfusion red blood cell survival kinetics in sickle cell disease and beta-Thalassemia: A biotin label approach.
    Transfusion. 2022;62:1984-1996.
    >> Share

    September 2022
  51. HOPKINS CK, Townsend M, Vassallo RR
    Leukoreduction filters: Still stuck on sickle trait red cells.
    Transfusion. 2022;62:1683-1687.
    >> Share

  52. LAURIDSEN L, Campbell-Lee SA
    Doing more with less: Patient blood management meets sickle cell disease management.
    Transfusion. 2022;62:1688-1692.
    >> Share

  53. GEHRIE EA, Petran L, Young PP
    Sickle cell trait results in a high leukoreduction quality control failure rate for whole blood donations.
    Transfusion. 2022;62:1727-1730.
    >> Share

  54. JONES JM, Swett AD, Crowe EP, Lawrence C, et al
    Implementation of national blood conservation recommendations at an adult sickle cell center.
    Transfusion. 2022;62:1763-1771.
    >> Share

    August 2022
  55. SEHEULT JN, Callum J, Delaney M, Drake R, et al
    Rate of D-alloimmunization in trauma does not depend on the number of RhD-positive units transfused: The BEST collaborative study.
    Transfusion. 2022;62 Suppl 1:S185-S192.
    >> Share

  56. COVINGTON ML, Cone-Sullivan JK, Andrzejewski C, Lu W, et al
    Unmasking delayed hemolytic transfusion reactions in patients with sickle-cell disease: Challenges and opportunities for improvement.
    Transfusion. 2022;62:1662-1670.
    >> Share

    July 2022
  57. BADE NA, Giri U, Wang H, Ershler WB, et al
    Reduced red cell transfusions and hospitalizations in sickle cell patients treated with voxelotor-Experience from a single center.
    Transfusion. 2022;62:1462-1464.
    >> Share

  58. FUJA C, Kothary V, Carll TC, Singh S, et al
    Hyperhemolysis in a patient with sickle cell disease and recent SARS-CoV-2 infection, with complex auto- and alloantibody work-up, successfully treated with tocilizumab.
    Transfusion. 2022;62:1446-1451.
    >> Share

  59. HANSEN DL, Moller S, Berentsen S, Frederiksen H, et al
    Mortality in cold agglutinin disease shows seasonal pattern.
    Transfusion. 2022;62:1460-1461.
    >> Share

    June 2022
  60. KRANENBURG FJ, Arbous SM, Caram-Deelder C, Putter H, et al
    Predicting organ functioning with and without blood transfusion in critically ill patients with anemia.
    Transfusion. 2022 Jun 30. doi: 10.1111/trf.16998.
    >> Share

  61. PROCHASKA M, Salcedo J, Berry G, Meltzer D, et al
    Racial differences in red blood cell transfusion in hospitalized patients with anemia.
    Transfusion. 2022 Jun 3. doi: 10.1111/trf.16935.
    >> Share

    May 2022
  62. JOUZIER C, Cherait A, Cony-Makhoul P, Hamel JF, et al
    Red blood cell transfusion burden in myelodysplastic syndromes (MDS) with ring Sideroblasts (RS): A retrospective multicenter study by the Groupe Francophone des Myelodysplasies (GFM).
    Transfusion. 2022;62:961-973.
    >> Share

    April 2022
  63. CARLL T, Mei Z, Aldarweesh F, Wool GD, et al
    Alloimmunization rates in transfused patients receiving anti-CD47 antibody therapy.
    Transfusion. 2022;62:916-918.
    >> Share

    March 2022
  64. GUINN NR, Fuller M, Murray S, Aronson S, et al
    Treatment through a preoperative anemia clinic is associated with a reduction in perioperative red blood cell transfusion in patients undergoing orthopedic and gynecologic surgery.
    Transfusion. 2022 Mar 11. doi: 10.1111/trf.16847.
    >> Share

  65. MEENAN J, Hall R, Badle S, Chatterjee B, et al
    Tocilizumab in the management of posttransfusion hyperhemolysis syndrome in sickle cell disease: The experience so far.
    Transfusion. 2022;62:546-550.
    >> Share

  66. WADE J, Yee MEM, Easley KA, Pahz S, et al
    Procedural adverse events in pediatric patients with sickle cell disease undergoing chronic automated red cell exchange.
    Transfusion. 2022;62:584-593.
    >> Share

  67. YEE ME, Francis RO, Luban NLC, Easley KA, et al
    Glucose-6-phosphate dehydrogenase deficiency is more prevalent in Duffy-null red blood cell transfusion in sickle cell disease.
    Transfusion. 2022;62:551-555.
    >> Share

  68. SEEBER P, Dobel KU, Isbister JP, Murray K, et al
    Mortality and morbidity in non-transfusable and transfusable patients: A systematic review and meta-analysis.
    Transfusion. 2022;62:685-697.
    >> Share

    February 2022
  69. SCHIFFER CA
    Commentary on the prescient observations made by Emil J Freireich in Effectiveness of platelet transfusion in leukemia and aplastic anemia (Transfusion 1966; 6: 50-54).
    Transfusion. 2022;62:267-272.
    >> Share

    January 2022
  70. PATRIQUIN CJ, Pavenski K
    O, wind, if winter comes ... will symptoms be far behind?: Exploring the seasonality (or lack thereof) and management of cold agglutinin disease.
    Transfusion. 2022;62:2-10.
    >> Share

  71. ROTH A, Fryzek J, Jiang X, Reichert H, et al
    Complement-mediated hemolysis persists year round in patients with cold agglutinin disease.
    Transfusion. 2022;62:51-59.
    >> Share

  72. KRIGSTEIN M, Cromer N
    Navigating the challenges of Bombay phenotype (Oh ) and twin pregnancy; a case report and literature review.
    Transfusion. 2022;62:247-251.
    >> Share

  73. CARR NR, Henry E, Bahr TM, Ohls RK, et al
    Fetomaternal hemorrhage: Evidence from a multihospital healthcare system that up to 40% of severe cases are missed.
    Transfusion. 2022;62:60-70.
    >> Share

    December 2021
  74. LEE ES, Hendrickson JE, Tormey CA
    RBC alloimmunization and daratumumab: Are efforts to eliminate interferences and prevent new antibodies necessary?
    Transfusion. 2021;61:3283-3285.
    >> Share

  75. KARKI S, Davison TE, Liu B, Bell K, et al
    Visits to general practitioners after iron-related deferrals from blood donation in middle-aged and older Australian blood donors.
    Transfusion. 2021;61:3335-3343.
    >> Share

  76. ARNONI CP, Vendrame T, Muniz J, Cortez A, et al
    RHCE diversity among Brazilian patients with sickle cell disease (SCD) and selected groups of blood donors.
    Transfusion. 2021;61:3473-3482.
    >> Share

    November 2021
  77. DIANA JS, Manceau S, Leblanc T, Magnani A, et al
    A new step in understanding stem cell mobilization in patients with Fanconi anemia: A bridge to gene therapy.
    Transfusion. 2021 Nov 9. doi: 10.1111/trf.16721.
    >> Share

  78. LIOU S, Bakic L, Manakelew B, Guillermo F, et al
    False anemia due to total parenteral nutrition and lipid emulsion contamination.
    Transfusion. 2021 Nov 5. doi: 10.1111/trf.16728.
    >> Share

  79. HAMILTON CM, Davenport DL, Bernard AC
    Demonstration of a U.S. nationwide reduction in transfusion in general surgery and a review of published transfusion reduction methodologies.
    Transfusion. 2021;61:3119-3128.
    >> Share

  80. YAMAMOTO T, Bikhet MH, Marques MB, Nguyen HQ, et al
    Initial experimental experience of triple-knockout pig red blood cells as potential sources for transfusion in alloimmunized patients with sickle cell disease.
    Transfusion. 2021;61:3104-3118.
    >> Share

    October 2021
  81. KAMESAKI T
    Diagnostic algorithm for classification and characterization of direct antiglobulin test-negative autoimmune hemolytic anemia with 1-year clinical follow-up.
    Transfusion. 2021 Oct 19. doi: 10.1111/trf.16709.
    >> Share

  82. CALLAN MB, Thawley VJ, Marryott KA, Shabro A, et al
    Hemolytic anemia blunts the cytokine response to transfusion of older red blood cells in mice and dogs.
    Transfusion. 2021 Oct 11. doi: 10.1111/trf.16690.
    >> Share

  83. TANG CH, Furnback W, Wang BCM, Tang J, et al
    Relationship between transfusion burden, healthcare resource utilization, and complications in patients with beta-thalassemia in Taiwan: A real-world analysis.
    Transfusion. 2021;61:2906-2917.
    >> Share

  84. LAL A, Wong T, Keel S, Pagano M, et al
    The transfusion management of beta thalassemia in the United States.
    Transfusion. 2021;61:3027-3039.
    >> Share

  85. ABEL GA, Klepin HD, Magnavita ES, Jaung T, et al
    Peri-transfusion quality-of-life assessment for patients with myelodysplastic syndromes.
    Transfusion. 2021;61:2830-2836.
    >> Share

    September 2021
  86. GADI SRV, Brunker PAR, Al-Samkari H, Sykes DB, et al
    Severe Autoimmune Hemolytic Anemia Following Receipt of SARS-CoV-2 mRNA Vaccine.
    Transfusion. 2021 Sep 22. doi: 10.1111/trf.16672.
    >> Share

  87. ANG AL, Lim CY, Ng WY, Lam JCM, et al
    Non-transfusion dependent thalassemia is independently associated with higher alloimmunization risk than transfusion dependent thalassemia and would benefit the most from extended red cell antigen-matching.
    Transfusion. 2021;61:2566-2577.
    >> Share

  88. AVECILLA ST, Boulad F, Yazdanbakhsh K, Sadelain M, et al
    Process and procedural adjustments to improve CD34+ collection efficiency of hematopoietic progenitor cell collections in sickle cell disease.
    Transfusion. 2021;61:2775-2781.
    >> Share

    August 2021
  89. TANHEHCO YC, Delgado AC
    Red blood cell reduction of a sickle cell disease stem cell product.
    Transfusion. 2021 Aug 29. doi: 10.1111/trf.16633.
    >> Share

  90. SALINAS CISNEROS G, Webb J, Luban NLC, Nickel RS, et al
    Impact of universal irradiation on chronic transfusion for sickle cell disease.
    Transfusion. 2021;61:2290-2294.
    >> Share

  91. CHIDAMBARAM V, Jones JM, Lokhandwala PM, Bloch EM, et al
    Low rates of transfusion-transmitted infection screening in chronically transfused adults with sickle cell disease.
    Transfusion. 2021;61:2421-2429.
    >> Share

  92. MUNIZ JG, Arnoni C, Medeiros R, Vendrame T, et al
    Antigen matching for transfusion support in Brazilian female patients with sickle cell disease to reduce RBC alloimmunization.
    Transfusion. 2021;61:2458-2467.
    >> Share

  93. RANKIN A, Darbari D, Campbell A, Webb J, et al
    Screening for new red blood cell alloantibodies after transfusion in patients with sickle cell disease.
    Transfusion. 2021;61:2255-2264.
    >> Share

    July 2021
  94. CAHILL CM, Alhasson B, Blumberg N, Melvin A, et al
    Preoperative anemia management program reduces blood transfusion in elective cardiac surgical patients, improving outcomes and decreasing hospital length of stay.
    Transfusion. 2021 Jul 15. doi: 10.1111/trf.16564.
    >> Share

  95. SARKER TT, Delvadia B, Li S, Roback JD, et al
    Mizuho hemoglobinopathy, presenting with severe hemolytic anemia and multisystem organ failure secondary to exertion.
    Transfusion. 2021 Jul 1. doi: 10.1111/trf.16522.
    >> Share

  96. HASAN RA, Asif M, Tuott EE, Stansbury LG, et al
    Rates of delayed hemolytic transfusion reactions observed in a trauma center.
    Transfusion. 2021;61:2035-2040.
    >> Share

  97. GOWDA L, Vege S, Kessler D, Shaz B, et al
    Screening of blood donors for sickle cell trait using a DNA-based approach: Frequency in a multiethnic donor population.
    Transfusion. 2021;61:2008-2013.
    >> Share

    June 2021
  98. GAMBERINI MR, Fortini M, Stievano A, Calori E, et al
    Impact of the preparation method of red cell concentrates on transfusion indices in thalassemia patients: A randomized crossover clinical trial.
    Transfusion. 2021;61:1729-1739.
    >> Share

  99. GODBEY EA, Anderson MR, M Bachmann L, Sanford KW, et al
    How do we monitor hemoglobin S in patients who undergo red blood cell exchange and take voxelotor?
    Transfusion. 2021;61:1680-1683.
    >> Share

  100. BAROUQA M, Szymanski J, Nelson R, Jofre S, et al
    Bone marrow necrosis and fat embolism syndrome in sickle cell disease: A rapidly deteriorating complication.
    Transfusion. 2021;61:1678-1679.
    >> Share

    May 2021
  101. ANANDAPPA AJ, Stefely JA, Hasserjian RP, Dzik WH, et al
    Multiorgan failure in a fatal case of autoimmune hemolytic anemia.
    Transfusion. 2021 May 27. doi: 10.1111/trf.16513.
    >> Share

  102. LI S, He Z, Mo C, Ji Y, et al
    Hyporegenerative anemia in anti-M-associated hemolytic disease of the fetus.
    Transfusion. 2021 May 3. doi: 10.1111/trf.16350.
    >> Share

  103. MCOMISH C
    A monthly roundup of key articles in other journals.
    Transfusion. 2021;61:1355-1358.
    >> Share

  104. GUARENTE J, Palladino M, Babariya S, Hayes C, et al
    Iatrogenic arteriovenous fistula in patient with sickle cell disease undergoing red blood cell exchange.
    Transfusion. 2021;61:1361-1362.
    >> Share

    April 2021
  105. THEMELIN N, Biston P, Massart J, Lelubre C, et al
    Effects of red blood cell transfusion on global oxygenation in anemic critically ill patients.
    Transfusion. 2021;61:1071-1079.
    >> Share

  106. JUSKEWITCH JE, Murray JD, Norgan AP, Moldenhauer SK, et al
    In from the cold: M-protein light chain glycosylation is positively associated with cold agglutinin titer levels.
    Transfusion. 2021;61:1302-1311.
    >> Share

    March 2021
  107. NGUYEN TN, Maenulein E, Fihman V, Vinatier I, et al
    Serologic characteristics of oxaliplatin antibodies in 15 patients with drug-induced immune hemolytic anemia.
    Transfusion. 2021 Mar 9. doi: 10.1111/trf.16360.
    >> Share

  108. ATAGA KI, Elsherif L, Wichlan D, Wogu AF, et al
    A pilot study of the effect of rivaroxaban in sickle cell anemia.
    Transfusion. 2021 Mar 4. doi: 10.1111/trf.16343.
    >> Share

    February 2021
  109. YATES B, Molloy E, Dulau-Florea A, Braylan R, et al
    Daratumumab for delayed RBC engraftment following major ABO mismatched haploidentical bone marrow transplantation.
    Transfusion. 2021 Feb 2. doi: 10.1111/trf.16281.
    >> Share

  110. DURIEUX-ROUSSEL E, Laget L, Filosa L, Izard C, et al
    RHCE*01 (c.499A>G, p.Met167Val) allele: Weak RhE expression which does not require the E-specific proline 226.
    Transfusion. 2021;61:E18-E20.
    >> Share

  111. ZIEMBA Y, Xu C, Fomani KM, Nandi V, et al
    Safety and benefits of automated red cell depletion-exchange compared to standard exchange in patients with sickle cell disease undergoing chronic transfusion.
    Transfusion. 2021;61:526-536.
    >> Share

  112. DINARDO CL, Oliveira TGM, Kelly S, Ashley-Koch A, et al
    Diversity of variant alleles encoding Kidd, Duffy, and Kell antigens in individuals with sickle cell disease using whole genome sequencing data from the NHLBI TOPMed Program.
    Transfusion. 2021;61:603-616.
    >> Share

  113. SLICHTER SJ, Gernsheimer T, LeBlanc R, Townsend-McCall D, et al
    Fecal blood loss: A quantitative method of evaluating hemostasis in patients with thrombocytopenia.
    Transfusion. 2021;61:393-403.
    >> Share

    January 2021
  114. ANDERSEN LH, Jacob EK, McThenia SS, Tauscher CD, et al
    Hemolytic disease and reticulocytopenia of the newborn attributable to maternal immunoglobulin G anti-M reacting optimally at cold temperatures.
    Transfusion. 2021 Jan 14. doi: 10.1111/trf.16252.
    >> Share

  115. SPENCER BR, Fox MP, Wise LA, Cable RG, et al
    Iron status and self-reported fatigue in blood donors.
    Transfusion. 2021;61:124-133.
    >> Share

  116. JUSKEWITCH JE, Zuccarelli MD, Berg HE, Summerfield DD, et al
    Transfusion medicine illustrated: When less is more for HLA antibodies.
    Transfusion. 2021;61:9-11.
    >> Share

  117. VASSALLO RR
    Donor iron depletion in context.
    Transfusion. 2021;61:318-321.
    >> Share

  118. RICHARDS AL, Qiu A, Zotti FD, Sheldon K, et al
    Autoantigen presentation by splenic dendritic cells is required for RBC-specific autoimmunity.
    Transfusion. 2021;61:225-235.
    >> Share

  119. SRIVASTAVA K, Albasri J, Alsuhaibani OM, Aljasem HA, et al
    SCAR: The high-prevalence antigen 013.008 in the Scianna blood group system.
    Transfusion. 2021;61:246-254.
    >> Share

  120. SAYERS M
    Donor iron nutrition: Which precaution prevails?
    Transfusion. 2021;61:313-317.
    >> Share

    December 2020
  121. JACOBS J, Eichbaum Q
    COVID-19 associated with severe autoimmune hemolytic anemia.
    Transfusion. 2020 Dec 3. doi: 10.1111/trf.16226.
    >> Share

  122. PAGANO MB, Cataife G, Fertrin KY, Gernsheimer T, et al
    Blood use and transfusion needs at a large health care system in Washington state during the SARS-CoV-2 pandemic.
    Transfusion. 2020;60:2859-2866.
    >> Share

    October 2020
  123. BEVERINA I, Scalvini R, Brando B
    "Camel humps"-shaped red blood cell histogram in a woman with extreme anemia treated with intravenous iron.
    Transfusion. 2020 Oct 28. doi: 10.1111/trf.16154.
    >> Share

  124. GARCIA-GARCIA I, Cid J, Palomino A, Gine E, et al
    Role of therapeutic plasma exchanges in refractory severe warm autoimmune hemolytic anemia: Presentation of two case reports.
    Transfusion. 2020 Oct 22. doi: 10.1111/trf.16143.
    >> Share

  125. STEUER LV, Kondo AT, Cipolletta AN, Sakashita AM, et al
    Predictive factors for the development of anemia after hematopoietic stem cell donation.
    Transfusion. 2020 Oct 14. doi: 10.1111/trf.16124.
    >> Share

  126. MAZZEFFI M, Taneja M, Porter S, Chow JH, et al
    Anemia, sex, and race as predictors of morbidity or mortality after knee arthroplasty surgery.
    Transfusion. 2020 Oct 5. doi: 10.1111/trf.16111.
    >> Share

  127. FERGUSSON DA, Lalu MM
    Mind the evidence gap: The need for trials in the prevention and management of perioperative anemia in noncardiac surgery.
    Transfusion. 2020;60:2168-2170.
    >> Share

    September 2020
  128. SANCHEZ-DURAN MA, Higueras MT, Aviles-Garcia M, Maiz N, et al
    Perinatal outcomes and central nervous system abnormalities following intrauterine fetal transfusion: 17 years' experience in a tertiary center.
    Transfusion. 2020 Sep 21. doi: 10.1111/trf.16087.
    >> Share

  129. NIZZI F, Rees M, Salzberg D, Ngwube A, et al
    Successful management of sirolimus toxicity in a hematopoietic stem cell transplant patient using automated red blood cell exchange.
    Transfusion. 2020 Sep 5. doi: 10.1111/trf.16064.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016